Product Recalls in Connecticut

Product recalls affecting Connecticut — including food, drugs, consumer products, medical devices, and vehicles distributed to Connecticut. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,617 recalls have been distributed to Connecticut in the last 12 months.

51,038 total recalls
2,617 in last 12 months

Showing 1030110320 of 13,380 recalls

DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Alprostadil 40 mcg/ml Injection Recalled by The Compounding Pharmacy of...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Testosterone 62.5 mg Pellet Recalled by The Compounding Pharmacy of America...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Estradiol 4 mg Recalled by The Compounding Pharmacy of America Due to Lack...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Zonisamide capsules Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets Recalled by American Health Packaging Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Clarithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets Recalled by American Health Packaging Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Famotidine tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets Recalled by American Health Packaging Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2015· Apotex Inc.

Recalled Item: Losartan potassium tablets USP Recalled by Apotex Inc. Due to Failed Content...

The Issue: Failed Content Uniformity Specifications: The product may not meet the limit...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2015· Apotex Inc.

Recalled Item: Enalapril maleate and hydrochlorothiazide tablets USP Recalled by Apotex...

The Issue: Failed Content Uniformity Specifications: The product may not meet the limit...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2015· Apotex Inc.

Recalled Item: Losartan potassium tablets USP Recalled by Apotex Inc. Due to Failed Content...

The Issue: Failed Content Uniformity Specifications: The product may not meet the limit...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2015· Apotex Inc.

Recalled Item: Losartan potassium tablets USP Recalled by Apotex Inc. Due to Failed Content...

The Issue: Failed Content Uniformity Specifications: The product may not meet the limit...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund